newsfilter
← Latest News
GlobeNewswire·

Cerenome Reports Second Quarter 2026 Financial Results and Business Update

HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (NASDAQ:CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics,